NEXUS SURGICAL AND MEDICARE LIMITED

Financial Services · Finance

BSE: 538874
₹31.27
▼ -0.19 (-0.60%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
85/100
Strong
Valuation
50/100
Fairly Valued
Momentum
53/100
Neutral

QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹17 Cr
PE (TTM)
22.2
Industry median 22.8 (115 companies)
Price to Book
9.5
PEG (TTM)
0.4
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
33.6
Free Cash Flow
₹0 Cr
as of March 31, 2026
Industry median ₹-0 Cr (536 companies)
EPS Growth (YoY)
32.14%
as of June 30, 2026
Industry median 25.00% (187 companies)
Net Profit Growth (TTM)
37.43%
as of June 30, 2026
Industry median 0.00% (481 companies)
Operating Revenue Growth (TTM)
31.64%
as of June 30, 2026
Industry median 0.00% (476 companies)
Profit Growth (YoY)
33.33%
as of June 30, 2026
Industry median 12.66% (188 companies)
Revenue Growth (YoY)
47.71%
as of June 30, 2026
Industry median 8.05% (138 companies)
Current Ratio
1.96
as of March 31, 2026
Industry median 5.29 (212 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.00 (206 companies)
Interest Coverage
Data unavailable.
Net Margin
8.01%
as of June 30, 2026
Industry median 21.71% (183 companies)
Operating Margin (EBIT)
10.71%
as of June 30, 2026
Industry median 29.93% (192 companies)
Operating Margin (TTM)
13.73%
as of June 30, 2026
Industry median 31.63% (395 companies)
Return on Assets
17.94%
as of March 31, 2026
Industry median 0.85% (493 companies)
Return on Capital Employed
48.67%
as of March 31, 2026
Industry median 1.93% (197 companies)
Return on Equity
36.39%
as of March 31, 2026
Industry median 1.37% (491 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

5 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (36.4%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.6%
Low 30.0000 · High 32.0900
1W return
-0.7%
Low 29.8000 · High 32.4000
1M return
50.3%
Low 21.2000 · High 35.7900
52W return
23.3%
Low 17.0000 · High 35.7900
Lifetime High ₹64.7000 (May 11, 2017)
Lifetime Low ₹2.2800 (Oct. 27, 2021)

Full price history and technicals →

EMA & SMA

Bullish4
Bearish2
5D
31.4
10D
31.3
20D
29.8
50D
25.0
100D
20.8
200D
15.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
72.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

31.12
Pivot
First resistance32.24
Second resistance33.21
Third resistance34.33
First support30.15
Second support29.03
Third support28.06
Day RSI59.2
Day MFI56.6
Day MACD2.36
Day MACD signal2.91

Beta

1M-2.32
3M-2.17
1Y-2.17
3Y0.14

Price change analysis

↑ 50.3%
Over 1 Month
LowHigh
21.2035.79
↑ 23.3%
Over 3 Months
LowHigh
17.0035.79
↑ 23.3%
Over 6 Months
LowHigh
17.0035.79
↑ 23.3%
Over 1 Year
LowHigh
17.0035.79
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 22.2 (own history: 18.0–103.7)
Buy Zone
Revenue (June 30, 2026)
₹3 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.3700

Ranks #359 of 510 in Finance by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter18.73%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 18.73% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
22 May 2026 ACQUITOR FINANCIAL SERVICES PVT.LTD. Bulk Buy 43,726 20.0000 BSE
22 May 2026 RUCHEE CHOTRA Bulk Sell 44,701 20.0000 BSE
20 May 2026 MANOJ KUMAR Bulk Sell 39,675 19.0500 BSE
20 May 2026 ACQUITOR FINANCIAL SERVICES PVT.LTD. Bulk Buy 40,091 19.0500 BSE
18 May 2026 RUCHEE CHOTRA Bulk Sell 35,299 19.0000 BSE
18 May 2026 RISHABH NEGI Bulk Buy 35,424 19.0000 BSE
25 Sep 2025 LAXMAN SOPAN WAGHMODE Bulk Sell 55,555 16.0700 BSE
30 Jan 2025 ACQUITOR FINANCIAL SERVICES PVT.LTD. Bulk Buy 35,000 14.7200 BSE
30 Jan 2025 RAJEEV KUMAR SINGH Bulk Sell 42,583 14.8500 BSE
27 Nov 2024 HARIVARDHAN STEEL & ALLOYS PRIVATE LIMTED Bulk Buy 34,931 19.0200 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Nexus Commodities & Technologies Ltd. to NEXUS SURGICAL AND MEDICARE LIMITED

All corporate actions →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 AGM/EGM Nexus Surgical And Medicare Ltd - 538874 - Shareholder Meeting / Postal Ballot-Outcome of AGM
2 Sep 2026 Board Meeting Nexus Surgical And Medicare Ltd - 538874 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, 2Nd September, 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (36.4%)
  • Low financial leverage (Debt/Equity 0.00)
  • Healthy liquidity (Current Ratio 1.96)
  • Strong revenue growth YoY (47.7%)

Weaknesses

Data unavailable.

Opportunities

  • PEG below 1 (0.40) -- earnings growth outpacing its own valuation

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about NEXUS SURGICAL AND MEDICARE LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.